SciSparc SPRC
NASDAQ SPRC
$0.38 -0.04 (-9.52%)
At close: Nov 10, 2026 · 4:00 PM EST

SciSparc (SPRC) Return on Equity [ROE] (2017 - 2018)

Updated

SciSparc's Return on Equity [ROE] was -177.85% in FY2025, down 97.18 percentage points from -80.67% in FY2024.

Analysis

SciSparc (SPRC) Return on Equity [ROE] (2017 - 2018) Analysis & Trends

From FY2016 onward, SciSparc has reported Return on Equity [ROE] for 10 years.

  • Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -667.46 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2016.
  • Per Business Quant data, Return on Equity [ROE] in earlier years was -80.67% in FY2024 (-7.29 pp), -73.37% in FY2023 (-108.90 pp), 35.53% in FY2022 (+156.50 pp) and -120.97% in FY2021 (-610.58 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 SciSparc 138,868.72 -6.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -620.23%
Sep 30, 2018 -3.17%
Jun 30, 2018 -51.96%
Mar 31, 2018 -49.38%
Dec 31, 2017 -54.52%
Sep 30, 2017 11.48%
Jun 30, 2017 16.13%
Mar 31, 2017 52.41%
API Access

SciSparc Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SPRC&period=max&api_key=YOUR_API_KEY